Seventy percent of rabies infections acquired in the United States attributed to bats
A 3-day course of either 300 mcg/kg/day or 600 mcg/kg/day of ivermectin may have similar mosquitocidal effects for up to 28-days postfeeding via membrane or direct skin feeding.
The Food and Drug Administration (FDA) has approved Dengvaxia (dengue tetravalent vaccine, live; Sanofi) for the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4.
Significant changes may have occurred in France, in the population that developed malaria after travel in endemic areas, which implies that preventative strategies need to be adapted.
The first confirmed identification of the bloodsucking “kissing bug” in Delaware involves one that bit a girl on the face last summer.
The Food and Drug Administration has granted an investigational treatment for severe malaria Breakthrough Therapy designation.
The vaccine, called Mosquirix, was approved by the European Medicines Agency in 2015
Frequently repeated mass administration of ivermectin during transmission season may reduce the incidence of uncomplicated malaria episodes in children living in endemic regions, according to study results published in the Lancet.1 Since 2017, when researchers at the World Health Organization suggested that the global fight against malaria had stalled,2 novel ways to prevent the transmission…
Only 1.0 percent of reported cases of spotted fever rickettsioses (SFR) meet the confirmed case definition.
The drug artesunate will become the first-line treatment for severe malaira in the US.
The addition of azithromycin to seasonal malaria chemoprevention may reduce mortality and morbidity in African children.
An expert meeting convened at NIAID, NIH, in Rockville, Maryland, in 2016 to discuss the rationale and design of malaria vaccine trials in pregnant women.
Compared with placebo, single-dose tafenoquine significantly lowered risk for Plasmodium vivax malaria relapse at 6 months.
A novel malaria vaccine candidate is well tolerated and induced functionally active antibodies.
The TIDES trial is investigating the safety and efficacy of 2 doses of TAK-003 in preventing dengue fever caused by any of the 4 dengue virus serotypes.
Screening blood donations for Babesia microti in endemic areas eliminates transfusion-transmitted babesiosis effectively.
Tribendimidine 400 mg has demonstrated efficacy and tolerability in children with mild hookworm infections.
Chemoprophylaxis with tafenoquine is safe and effective for preventing malaria in healthy non-immune individuals challenged with blood stage P falciparum.
Placental malaria has a profound effect on the fetal immune system, and prenatal malaria exposure categories may drive heterogeneity to malaria susceptibility.
A single triple-drug treatment for lymphatic filariasis may prove to be more effective and potent than a double-drug regimen.